Shuangcheng Pharmaceutical: An indicative announcement on abnormal stock trading fluctuations and risks of Hainan Shuangcheng Pharmaceutical Co., Ltd.
Shuangcheng Pharmaceutical: An indicative announcement on serious abnormal fluctuations and risks in the stock trading of Hainan Shuangcheng Pharmaceutical Co., Ltd.
Shuangcheng Pharmaceutical: Announcement of Hainan Shuangcheng Pharmaceutical Co., Ltd. on not holding a shareholders\' meeting
Shuangcheng Pharmaceutical: Announcement of Hainan Shuangcheng Pharmaceutical Co., Ltd. on the shareholding situation of the top ten shareholders and the top ten tradable shareholders before the trading day before planning a major asset restructuring and suspension of trading
Shuangcheng Pharmaceutical: Hainan Shuangcheng Pharmaceutical Co., Ltd.\'s general risk warning on issuing shares and paying cash to purchase assets and raising supporting capital and related transactions, and an indicative announcement on the resumption of the company\'s stock trading
Shuangcheng Pharmaceutical: Announcement of Hainan Shuangcheng Pharmaceutical Co., Ltd. on the company affected by the typhoon
Shuangcheng Pharmaceutical: Announcement of Hainan Shuangcheng Pharmaceutical Co., Ltd. on planning major asset restructuring and the progress of related transactions and the continued suspension of trading
Shuangcheng Pharmaceutical: Semi-Annual Financial Report
Shuangcheng Pharmaceutical: 2024 Semi-Annual Financial Report
Shuangcheng Pharmaceutical: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Shuangcheng Pharmaceutical: Announcement of Hainan Shuangcheng Pharmaceutical Co., Ltd. on completing the registration of industrial and commercial changes and obtaining a business license
Shuangcheng Pharmaceutical: Announcement of Hainan Shuangcheng Pharmaceutical Co., Ltd. on planning major asset restructuring and related transactions
Hainan Shuangcheng Pharmaceuticals: Announcement on Changes to Pharmaceutical Manufacturing License of Subsidiary Controlled by Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Hainan Shuangcheng Pharmaceuticals: Announcement of Hainan Shuangcheng Pharmaceuticals Co., Ltd. regarding cumulative changes in the shareholding percentage of controlling shareholders, actual controllers and their concerted action parties exceeding 1%.
Hainan Shuangcheng Pharmaceuticals: Announcement on the signing of the Technical Service Contract and related trade by Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Hainan Shuangcheng Pharmaceuticals: Announcement of the resolution of the first extraordinary shareholders' meeting of Hainan Shuangcheng Pharmaceuticals Co., Ltd. in 2024.
Hainan Shuangcheng Pharmaceuticals: Announcement of Hainan Shuangcheng Pharmaceuticals Co., Ltd. regarding the change of pharmaceutical production license.
Hainan Shuangcheng Pharmaceuticals: Legal Opinion of Zhong Lun Law Firm on the First Extraordinary General Meeting of Hainan Shuangcheng Pharmaceuticals Co., Ltd.'s Shareholders in 2024.
Hainan Shuangcheng Pharmaceuticals: Notice of Hainan Shuangcheng Pharmaceuticals Limited's First Extraordinary General Meeting of Shareholders in 2024.
Hainan Shuangcheng Pharmaceuticals: Announcement on Changes to Pharmaceutical Manufacturing License of Subsidiary Controlled by Hainan Shuangcheng Pharmaceuticals Co., Ltd.
No Data
No Data